VIVACA® Addressing Symptoms

Symptoms targeted by VIVACA® include:

  • Hot flushes
  • Night sweats
  • Mild depression associated with menopause
  • Low energy

We address these symptoms through a formulation that includes:

Black Cohosh Root Cimicifuga (black cohosh)
Based on current clinical studies and historical evidence, Black Cohosh is used to help relieve premenstrual and menopausal symptoms, as well as to relax skeletal muscles and ease nervous tension.

St. John’s Wort Herb Hypericum (St. John’s Wort)
St. John’s Wort has demonstrated positive effects on depression, relief of restlessness or nervousness and treat symptoms of sleep disorders based on clinical studies and historical data.

Red Clover Herb Trifolium pretense L. (red clover):
Based on clinical testing and historical use, Red Clover Herb is used for reducing hot flashes.

Rhodiola Root (Rhodiola rosa actives)
Rhodiola has demonstrated significant improvements in physical fitness, psychomotor function, mental performance and general well being, based on historical use and clinical trials. Subjects receiving the rhodiola extract also reported statistically significant reductions in mental fatigue, improved sleep patterns, a reduced need for sleep, greater mood stability, and a greater motivation to study.


A Naturopathic review of the four botanical ingredients in VIVACA®in the management of menopausal symptoms

Written By Dr. Chi Hung La, ND (Naturopathic Clinician)

VIVACA® is a unique product in many aspects:

1) It is in a liquid form delivery, which makes the concentrated herb extracts more biologically available.

2) Formulated herbs are well used and researched in their respective clinical actions.

3) Formulated to work on multiple levels of menopause.

Clinical usages:

  • Hot flushes and night sweats are being addressed by the combination of  Cimicifuga racemosa (black cohosh)1,3,4  and Trifolium pratense (red clover)8
  • Neurological and neuroendrocrine symptoms such as: anxiety, restlessness, sleeplessness/insomnia, and depression will be addressed with Hypericum perforatum (St. John’s Wort)6,7 and Rhodiola rosea (Rhodiola)5,9
  • Memory and Changes in Cognition related to estrogen withdrawal has been considered in this formula with the use of phytoestrogens (black cohosh and red clover).  Plus Rhodiola will also play a significant role in enhancing cognition. 2
  • Atrophy of Vaginal and Genitourinary tissue can be reduced with red clover. 10,12

Recommended Dose for Best result:

  • Cimicifuga racemosa (black cohosh) = 80mg to 160mg  (at 4mg of triterpenes) daily
  • Trifolium pratense (red clover) = at 40mg – 80 mg of isoflavones daily
  • Rhodiola rosea (Rhodiola) = 100mg-200mg daily (at 3:1 ratio of 6% rosavin/2% salidroside)
  • Hypericum perforatum (St. John’s Wort) = 150mg – 300mg daily (0.4% Hypericins)

VIVACA® is able to achieve these daily recommended doses without compromising any lost of activity to the herbs.


  1. Borrelli F. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet Gynecol – 01-NOV-2008; 199(5): 455-66
  2. Brown RP. Rhodiola rosea: A Phytomedicinal Overview. HerbalGram. 2002;56:40-52 © American Botanical Council
  3. Cheema D. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet – 01-NOV-2007; 276(5): 463-9
  4. Jeri A. The use of an isoflavone supplement to relieve hot flushes. The Female Patient 2002; 27: 35-37.
  5. Marina TF. Effect of Rhodiola rosea extract on bioelectrical activity of the cerebral cortex isolated to a different extent from the brain. In. Saratikov AS, editor. Stimulants of the Central Nervous System. Tomsk, Russia: Tomsk State University Press; 1968. p. 27-31.
  6. Muller WE et al. Effects of Hypericum extract on the expression of serotonin receptors, J Ger Psych Neuro 7 (suppl1): 1994; 63-64.
  7. Muller WE et al: Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract, Pharmacopsychiat 31 (suppl): 1998; 16-21.
  8. Powles TJ.  Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause Int. 2008 Mar;14(1):6-12.